SLFPAM
IHE icon

St. Louis Financial Planners Asset Management’s iShares US Pharmaceuticals ETF IHE Stock Holding History

St. Louis Financial Planners Asset Management’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,804
Closed -$1.2M – 37
2026
Q1 		$1.2M Buy
+13,804
New +$1.21M 0.68% 29

Other funds holding IHE

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $497M AUM 52.58% 1-Year Est. Return
CIA
Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
FP
FFG Partners Fort Lauderdale, Florida $352M AUM 70.53% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AFG
Arkansas Financial Group Little Rock, Arkansas $768M AUM 16.55% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

St. Louis Financial Planners Asset Management's IHE Position: Q2 2026 in Review

St. Louis Financial Planners Asset Management sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2026, closing a stake of 13,804 shares — an estimated $1.2M sold.

St. Louis Financial Planners Asset Management first reported a position in IHE in Q1 2026 and held it in 1 quarter. The position peaked at $1.2M in Q1 2026. 83 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • St. Louis Financial Planners Asset Management reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2026 after selling out during the quarter.
  • St. Louis Financial Planners Asset Management sold 13,804 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $1.2M.
  • St. Louis Financial Planners Asset Management first reported a position in iShares US Pharmaceuticals ETF in Q1 2026 and held it in 1 quarter.
  • St. Louis Financial Planners Asset Management's iShares US Pharmaceuticals ETF position peaked at $1.2M in Q1 2026.
  • 83 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on St. Louis Financial Planners Asset Management's 13F filing for Q2 2026, filed 7 Jul 2026.